Skip to content
healthcare.dev

Acyclovir suspension

NDC 17856-2170, Acyclovir, suspension, from Atlantic Biologicals Corp..

Product NDC
17856-2170
Status
Listed
Labeler
Atlantic Biologicals Corp.
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA217393
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/17856-2170 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ACYCLOVIR200 mg/5mL

Pharmacologic classes

DNA Polymerase Inhibitors [MoA]; Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]; Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]; Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]; Nucleoside Analog [EXT]

Package NDCNDC-11Package
17856-2170-11785621700172 CUP, UNIT-DOSE in 1 CASE (17856-2170-1) / 5 mL in 1 CUP, UNIT-DOSE
17856-2170-21785621700272 CUP, UNIT-DOSE in 1 CASE (17856-2170-2) / 10 mL in 1 CUP, UNIT-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5105272f-cff8-8898-e063-6394a90aabb5

Use it

Look up 17856-2170 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/17856-2170 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 17856-2170. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.